Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$20.45 - $26.49 $358,549 - $464,449
17,533 Added 21.99%
97,247 $2.1 Million
Q4 2023

Feb 01, 2024

BUY
$19.02 - $30.13 $1.52 Million - $2.4 Million
79,714 New
79,714 $1.77 Million
Q1 2023

Jun 27, 2023

BUY
$29.72 - $41.45 $620,523 - $865,434
20,879 Added 83.07%
46,014 $1.47 Million
Q4 2022

Feb 07, 2023

BUY
$30.23 - $38.71 $127,872 - $163,743
4,230 Added 20.23%
25,135 $897,000
Q3 2022

Nov 03, 2022

SELL
$22.51 - $38.27 $328,938 - $559,239
-14,613 Reduced 41.14%
20,905 $609,000
Q2 2022

Aug 08, 2022

BUY
$20.97 - $37.47 $256,693 - $458,670
12,241 Added 52.59%
35,518 $796,000
Q1 2022

May 09, 2022

BUY
$34.38 - $65.77 $800,263 - $1.53 Million
23,277 New
23,277 $859,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.42B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.